The 12-week kinetics of anti-SARS-CoV-2 antibodies in different haematological cancers after vaccination with BNT162b2

Br J Haematol. 2022 Jan;196(2):362-367. doi: 10.1111/bjh.17821. Epub 2021 Sep 6.

¹ Haematology Unit, Department of Research and Clinical Oncology, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
² Microbiology and Virology Unit, Dermatological Clinical and Research Department, IRCCS San Gallicano Institute, Rome, Italy.
³ Biostatistics and Bioinformatics Unit, Scientific Direction, Clinical Trial Center, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
⁴ Biological Tissue and Liquid Bank, Scientific Direction, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
⁵ SAFU Unit, Department of Research and Innovative Technologies, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
⁶ Oncogenomic and Epigenetic Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
⁷ Scientific Direction, IRCCS San Gallicano Institute, Rome, Italy.
⁸ Scientific Direction, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

No abstract available

Keywords: BNT162b2; haematological cancers; severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2).

Publication types